Insider filing · RVMD
Jack Anders
Chief Financial Officer
profile →
Revolution Medicines, Inc.
RVMD · Healthcare · 80 filings in 24 months
ticker →
Jack Anders sold $980K of Revolution Medicines (RVMD)
Executed Jan 7, disclosed Jan 9, 2 days later.
Value, as filed
$980K
10,000 sh × $98.00
Executed
Jan 7
the trade date, as filed
Disclosed
Jan 9
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
JAJack Anders (Chief Financial Officer) filed 8 Form 4 reports in the trailing twelve months (0 purchases, 8 sales), most often in Revolution Medicines, Inc. (RVMD). The largest single filing was $3.3M of RVMD (19,700 sh across 3 lots, as filed), executed Jun 24.
The name
RVMDHealthcare · Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Jack Anders in RVMD
RVMDSALE
Revolution Medicines, Inc.
$796K3,992 sh × $199.30
Exec Sep 16
Filed Sep 18 · 6:00 PM ET RVMDSALE Revolution Medicines, Inc. $3.3M
19,700 sh across 3 lots
Exec Jun 24
Filed Jun 26 · 5:30 PM ET RVMDSALE Revolution Medicines, Inc. $425K
2,722 sh × $156.12
Exec Jun 16
Filed Jun 18 · 5:30 PM ET RVMDSALE Revolution Medicines, Inc. $274K
2,753 sh × $99.48
Exec Mar 17
Filed Mar 19 · 5:30 PM ET RVMDSALE Revolution Medicines, Inc. $239K
3,104 sh × $77.09
Exec Dec 16 2025
Filed Dec 18 2025 · 5:30 PM ET RVMDSALE Revolution Medicines, Inc. $401K
5,418 sh × $74.00
Exec Nov 25 2025
Filed Nov 26 2025 · 5:30 PM ET RVMDSALE Revolution Medicines, Inc. $640K
10,000 sh × $64.00
Exec Nov 11 2025
Filed Nov 13 2025 · 5:30 PM ET RVMDSALE Revolution Medicines, Inc. $106K
2,320 sh × $45.82
Exec Sep 16 2025
Filed Sep 18 2025 · 5:30 PM ET